Ironwood Pharmaceuticals, Inc. (IRWD)
3.63
+0.07
(+1.97%)
USD |
NASDAQ |
Oct 20, 16:00
3.62
-0.01
(-0.28%)
After-Hours: 20:00
Ironwood Pharmaceuticals Gross Profit (TTM) : 387.48M for June 30, 2026
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 387.48M |
| March 31, 2026 | 359.67M |
| December 31, 2025 | 294.27M |
| September 30, 2025 | 337.08M |
| June 30, 2025 | 306.58M |
| March 31, 2025 | 315.70M |
| December 31, 2024 | 349.40M |
| September 30, 2024 | 376.38M |
| June 30, 2024 | 398.53M |
| March 31, 2024 | 411.75M |
| December 31, 2023 | 441.16M |
| September 30, 2023 | 430.98M |
| June 30, 2023 | 426.02M |
| March 31, 2023 | 415.78M |
| December 31, 2022 | 409.18M |
| September 30, 2022 | 419.09M |
| June 30, 2022 | 310.82M |
| March 31, 2022 | 213.95M |
| December 31, 2021 | 116.77M |
| September 30, 2021 | 115.36M |
| June 30, 2021 | 217.01M |
| March 31, 2021 | 305.80M |
| December 31, 2020 | 382.82M |
| September 30, 2020 | 381.88M |
| June 30, 2020 | 407.72M |
| Date | Value |
|---|---|
| March 31, 2020 | 409.83M |
| December 31, 2019 | 399.81M |
| September 30, 2019 | 393.92M |
| June 30, 2019 | 325.37M |
| March 31, 2019 | 308.03M |
| December 31, 2018 | 304.11M |
| September 30, 2018 | 277.18M |
| June 30, 2018 | 297.09M |
| March 31, 2018 | 284.68M |
| December 31, 2017 | 269.91M |
| September 30, 2017 | 274.43M |
| June 30, 2017 | 256.28M |
| March 31, 2017 | 245.92M |
| December 31, 2016 | 260.83M |
| September 30, 2016 | 225.21M |
| June 30, 2016 | 201.30M |
| March 31, 2016 | 170.10M |
| December 31, 2015 | 132.92M |
| September 30, 2015 | 107.34M |
| June 30, 2015 | 84.30M |
| March 31, 2015 | 61.03M |
| December 31, 2014 | 46.12M |
| September 30, 2014 | 22.61M |
| June 30, 2014 | 2.515M |
| March 31, 2014 | -1.513M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| AbbVie, Inc. | 45.98B |
| Xencor, Inc. | 94.79M |
| Viking Therapeutics, Inc. | -0.45M |
| IDEAYA Biosciences, Inc. | 229.62M |
| BioMarin Pharmaceutical, Inc. | 2.556B |